Clinical Trial Update: Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes AZD0516 as a monotherapy and in combination for metastatic prostate cancer, conducted in Phase 1 and Phase 2, with recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AZD0516

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING